The therapeutic effect of combined use of tolterodine and tamsulosin for benign prostate hyperplasia.

Trial Profile

The therapeutic effect of combined use of tolterodine and tamsulosin for benign prostate hyperplasia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Apr 2017 Primary endpoint (Urinary flow rate (Endpoints are maximum urinary flow rate and average urinary flow rate.)) has been met.
    • 04 Apr 2017 Primary endpoint (Quality of life) has been met.
    • 04 Apr 2017 Primary (International Prostate Symptom Score) endpoint has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top